The most critical financial conversation in American healthcare often happens after the patient leaves the building. It’s the moment a bill arrives, a payment plan is offered, and a patient’s ability to pay collides with a provider’s need to collect. For the team at PayZen, that moment is the wedge. The San Francisco Bay Area startup has built a platform that uses artificial intelligence to assess a patient’s financial capacity and generate a personalized, interest-free payment plan, which it then funds upfront for the hospital or physician group [TechCrunch, Nov 2021]. It’s a bet that underwriting medical affordability, not just creditworthiness, can improve both access to care and provider revenue. The company’s recent $32 million Series B and a separate $200 million debt facility, both closed in August 2024, provide the capital to scale that bet [TechCrunch, Aug 2024]. The debt, in particular, is the fuel for the core model: PayZen uses it to pay providers immediately, then collects from patients over time.
The Care Now, Pay Later Wedge
PayZen’s product is designed to slot into a provider’s existing digital billing flow. When a patient is presented with a bill or estimate, the platform can pre-screen them for financial assistance and, within a reported minute, generate a payment plan offer [PayZen, blog]. The key differentiator is the underwriting. Instead of relying solely on traditional credit scores, the company says its AI analyzes thousands of alternative data points to gauge a patient’s true ability to pay for care [PayZen, retrieved 2026]. This allows it to make an offer to what it claims is 100% of patients, always structured with no interest or fees [PayZen, blog]. For providers, the value proposition is straightforward: they get paid the full amount upfront by PayZen, ostensibly turning unpredictable patient receivables into immediate cash. The company reports that providers using its platform see collections rates increase by an average of 35% [TechCrunch, Aug 2024].
A Team Built on Fintech and Resilience
The founding trio brings a blend of consumer finance and technical expertise to a problem that sits at the intersection of both. CEO Itzik Cohen was previously CEO and co-founder of Beyond Finance, a consumer debt-resolution fintech, and held roles at Prosper Marketplace [Outcomes Rocket, Mar 2023]. His background also includes an earlier career as a professional basketball player in the Euroleague, a experience he has cited as formative for building resilience [Itzik Cohen | Bond Buyer, retrieved 2026]. Co-founder and Chief Revenue Officer Tobias Mezger also worked with Cohen at Prosper Marketplace, while co-founder Ariel Rosenthal serves as CTO [The Real Maxime Podcast, Nov 2023]. The executive bench has been fortified recently with the appointments of a CFO, COO, and Chief Legal Officer within the past six months, signaling a shift toward operational maturity as the company scales [Toarn, retrieved 2026].
Scaling the Capital Engine
The August 2024 financing package reveals the two-track strategy required to grow. The $32 million Series B, led by NEA with participation from existing investors like SignalFire and 7wireVentures, funds operations, technology, and sales [TechCrunch, Aug 2024]. The much larger $200 million debt facility, provided by Viola Credit and a syndicate of insurance companies, is the working capital that allows PayZen to purchase patient receivables from providers at volume. This structure is common in lending but carries specific execution risk in healthcare, where payment timelines can be long and defaults must be carefully managed.
| Round / Facility | Date | Amount | Lead Investor(s) |
|---|---|---|---|
| Seed | 2021 | $5 Million | Not Specified [TechCrunch, Nov 2021] |
| Series A | Nov 2021 | $15 Million | SignalFire [TechCrunch, Nov 2021] |
| Series B | Aug 2024 | $32 Million | NEA [TechCrunch, Aug 2024] |
| Debt Facility | Aug 2024 | $200 Million | Viola Credit [TechCrunch, Aug 2024] |
The Road Ahead and Inherent Risks
PayZen operates in a complex regulatory and financial environment. Its growth claims are notable,the company cites 3x annual revenue growth for three consecutive years,but remain self-reported without audited financials [Toarn, retrieved 2026]. The model’s success hinges on several factors aligning perfectly:
- Underwriting accuracy. The AI’s ability to predict patient repayment over months or years, using non-traditional data, is the core intellectual property. A miscalibration could lead to higher-than-expected defaults, eroding the margins on the debt facility.
- Provider adoption. While the platform reportedly requires no IT costs and can go live in four weeks, selling into large, slow-moving health systems is never trivial [PayZen, retrieved 2026]. The value proposition must clearly outweigh the operational change of integrating a new financial partner.
- Patient enrollment. The company’s reported 78% enrollment success rate inside a provider’s digital flow is a strong signal, but maintaining that rate at scale across diverse patient populations is another challenge [Fintech of the Day, retrieved 2026].
The most credible near-term risk is a macroeconomic downturn that strains household budgets and increases default rates across all consumer credit, including medical bills. PayZen’s answer likely lies in the granularity of its underwriting model, which aims to be more responsive to individual circumstances than a blunt credit score.
For patients facing a major procedure or a stack of chronic-care bills, the standard of care today is a patchwork of high-interest credit cards, medical credit cards with deferred interest traps, or simply letting bills go to collections, which damages credit and creates immense stress. PayZen’s bet is that a humane, zero-interest alternative, embedded at the point of care, can become a new standard. The disease state is financial toxicity, a well-documented side effect of healthcare that leads patients to delay or skip necessary treatment. The patient population is anyone with a medical bill they cannot pay in full today. If the model works, it could subtly rewire a small but painful part of the healthcare experience, turning a source of dread into a manageable path forward.
Sources
- [TechCrunch, August 2024] PayZen secures $32M Series B, $200M debt facility to expand ‘care now, pay later’ offering | https://techcrunch.com/2024/08/13/payzen-secures-23m-series-b-led-by-nea-and-200m-in-debt-to-expand-care-now-pay-later-offering/
- [TechCrunch, November 2021] PayZen secures $15M Series A for ‘care now, pay later’ healthcare platform | https://techcrunch.com/2021/11/17/payzen-secures-15m-series-a-for-care-now-pay-later-healthcare-platform/
- [Crunchbase News, November 2021] Medical Fintech Startup PayZen Raises $15M To Grow Its ‘Care Now, Pay Later’ Model | https://news.crunchbase.com/startups/medical-fintech-startup-payzen-ai-pay-later/
- [Outcomes Rocket, March 2023] Making Healthcare Affordable with Itzik Cohen | https://outcomesrocket.health/payzen/2022/03/
- [The Real Maxime Podcast, November 2023] Itzik Cohen, PayZen | https://podcasts.apple.com/us/podcast/itzik-cohen-payzen-the-fintech-series/id1655922798?i=1000636288292
- [PayZen] Patient Financing Solutions for Healthcare | https://payzen.com/
- [PayZen] PayZen’s “Care Now, Pay Later” Mission | https://blog.payzen.com/payzens-care-now-pay-later-mission-9a74db90db18?gi=60e6759686c6
- [Toarn, retrieved 2026] Source on growth and executive hires | (No URL provided in research)
- [Fintech of the Day, retrieved 2026] Source on enrollment rate | (No URL provided in research)
- [Itzik Cohen | Bond Buyer, retrieved 2026] Source on basketball background | https://www.bondbuyer.com/author/itzik-cohen